SYNLAB Emerging Markets and SYNLAB Group has announced the appointment of Mr. Patrick Asiamah as its new Chief Executive Officer effective March 1, 2022.
Prior to his appointment, Mr. Asiamah worked as Global Head of Portfolio & Product Marketing at mPharma, here in Ghana and abroad (Nigeria, Zambia and Kenya).
He has worked in other multinational organizations such as Sandoz, Ernest Chemist (Johnson & Johnson) and Shalina Healthcare.
Patrick holds an Executive MBA in Marketing Strategy and a Degree in Biochemistry. He has 15 years of expertise in Sales and Marketing, including Business Development, Sustaining Market Share Gains, Wrestling Market Leadership, and Business Operation Strategies.
Thomas Degott, CEO of SYNLAB Emerging Market, said “SYNLAB Ghana is positioned for significant growth, and we are thrilled Patrick has accepted this position, as it will allow him to bring the firm the tremendous opportunity that lies ahead for SYNLAB Ghana. We couldn’t be happier to have Patrick join our family and assist us and our clients achieve ongoing success”.
Patrick is eager to take a customer-focused healthcare organization like SYNLAB Ghana to the next level, with his many years of relevant experience.
“I am excited to be part of this team to deliver quality laboratory and radiology services to patients, doctors, and clients in Ghana. I believe, together, we can rewrite the narrative of SYNLAB Ghana and make impact in the medical diagnostics space,”he said.